Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "— CNBC'S Michael Bloom"


25 mentions found


Investors looking for artificial intelligence beneficiaries outside the megacap tech companies can search in a less buzzy part of markets — old economy stocks. "And that's our investing theme: Old economy companies that are embracing the digital revolution and the suppliers of the digital, you know, generative AI, cloud and cybersecurity tools," Tengler added. While megacap tech stocks have outperformed this year, helped by a surge of AI enthusiasm, the broader market has been left behind. But searching for more traditional companies embracing digitization could help investors identify less apparent beneficiaries of the AI boom, she said. "What we really like are the companies that are embracing digitization in their business, and improving margins," said Tengler, who holds oversized positions in the consumer discretionary, industrials and technology sectors of the market.
Persons: Nancy Tengler, Tengler, Ken Newman, Emerson, Newman, Oppenheimer, — CNBC's Michael Bloom Organizations: Nvidia, Emerson Electric, CNBC, Evoqua, Technologies, Carrier Global, Walmart, Starbucks
After three weeks without a speaker, House Republicans finally handed the gavel to Mike Johnson of Louisiana on Wednesday. The new House speaker arrives as lawmakers have been unable to pass spending legislation — with a Nov. 17 deadline nearing. Ukraine funding Another pressing issue is President Joe Biden's $106 billion defense supplemental request, on which Johnson has not signaled a clear position. "We expect Mr. Johnson and House Republicans will try to unbundle the proposal." Johnson is taking over as House speaker as the stocks market struggles.
Persons: Mike Johnson of, Johnson, Tobin Marcus, Jan Hatzius, Goldman Sachs, Marcus, Joe Biden's, Brian Gardner, Stifel's, Biden, Gardner, — CNBC's Michael Bloom Organizations: Republicans, Street, GOP, Wolfe Research, Senate, Ukraine, House Republicans, Nasdaq Locations: Mike Johnson of Louisiana, Israel, Ukraine, Washington
Here are some of the other stocks in Goldman's conviction list. Aside from TSMC, Goldman's conviction list stocks in this category include Chinese tech giant Hon Hai Precision Industry and Japanese electronics manufacturing company Ibiden . AI-empowered names The bank's conviction list stocks in this category include Chinese machine industry player Envicool , Japanese video game publisher Bandai Namco Entertainment and industrial equipment company Keyence . Goldman has an 83,000 yen price target on Keyence, giving it an upside of 56.7%. Stocks that are both Goldman named Chinese tech giants Alibaba and Baidu as its conviction list stocks that are both in the business of enabling and empowering AI.
Persons: Goldman Sachs, Daiki Takayama, TSMC, Goldman, Hai —, Envicool, Alibaba, — CNBC's Michael Bloom, Sheila Chiang Organizations: Taiwanese Semiconductor Manufacturing Company, New, Companies, Precision Industry, Bandai Namco Entertainment, Bandai Namco, Baidu, Alibaba Locations: Asia, New Taiwan
Alphabet's latest quarterly results left some analysts questioning whether investors should be buying the dominant search engine right now, or opting instead for some of its tech peers. "If you own the stock, the bad news is probably out of the way," said Bernstein analyst Mark Shmulik. We take up our ad revenue estimates, pull cloud and margins down, and we end up right back where we started." Profit margins contracted and the company also said it expects capital spending to increase in the fourth quarter and in 2024. Alphabet sank 9.8% in midday trading Wednesday, on pace for its worst one-day decline since March 2020.
Persons: Bernstein, Mark Shmulik, Wells, Ken Gawrelski, Lloyd Walmsley, Gawrelski, Bank of America's Justin Post, James Lee, — CNBC's Michael Bloom Organizations: Google, Microsoft, UBS, Bank of America's
Market volatility looks here to stay: Yields are still rising, a war is raging, and it's uncertain whether interest rates will stay higher for longer. Go for bonds Though volatility in the bond market has led to losses, some fund managers are saying that it's time to get back into this asset class, given that yields are high. Money market funds typically include short-term Treasurys. Bond yields move inversely to prices — that means a peak in interest rates may signal that bond prices have bottomed. When interest rates rise, bond prices typically fall as existing bonds with lower yields become less attractive.
Persons: Investors, David Katz, Katz, Bryn Jones, there's, Jones, Hide, Paul Meeks, Meeks, Steven Glass, Glass, Marsh McLennan, he's, they're, — CNBC's Michael Bloom Organizations: Treasury, Bank of America, Matrix Asset, CNBC Pro, gilts, U.S . Federal, Treasury Bond ETF, Pella Funds, Group, ASM, Taiwan's Locations: Israel, United States, China, U.S, Pella, Germany, Netherlands
If you held some bitcoin in your 60/40 portfolio back in 2014, you might have gotten a nice lift from the then-shadowy cryptocurrency, according to a Citi analysis of bitcoin returns. That return rose to 7.42% when analysts added a 1% allocation toward bitcoin. When committing 5% of the portfolio to the flagship cryptocurrency, that return rose to 9.3%, Citi analyst Alex Saunders said in a recent note. "Historically speaking, an allocation to Bitcoin would have enhanced portfolio returns," Saunders said in an Oct. 20 report. The firm also determined that to justify a 5% bitcoin allocation to a 60/40 portfolio, the cryptocurrency would need to generate annualized returns of 12% to 16%.
Persons: bitcoin, Alex Saunders, Saunders, Crypto, it's, CNBC's Michael Bloom Organizations: Citi, U.S Locations: U.S
SharkNinja 's history of innovation will set its stock for an extremely positive growth outlook, according to Goldman Sachs. The investment bank initiated coverage of the consumer products company with a buy rating, setting a 12-month price target of $52. Since listing on the New York Stock Exchange at $30 a share this summer , SharkNinja has rallied 36%. SN YTD mountain SN YTD chart Analyst Brooke Roach pointed to the firm's established track record of market disruption and solid growth across product lines. Meanwhile, the analyst highlighted the company's success in entering new categories, which could also provide incremental growth opportunities.
Persons: SharkNinja, Goldman Sachs, Brooke Roach, Roach, — CNBC's Michael Bloom Organizations: New York Stock Exchange
He forecasts stable dividend growth of 5% this year and 4% in 2024. Chevron has a dividend yield of 3.6% in 2023, with a dividend compound annual growth rate of 5% to 2025. Its dividend compound annual growth rate of 8% to 2025 means the company's payout to its investors will continue to grow. The firm also has the highest dividend compound annual growth rate of 29% on the list. Investors can expect their cash returns to grow further through 2025, with a dividend compound annual growth rate of 14%.
Persons: Goldman Sachs, David Kostin, Kostin, Goldman, Hess, Blackstone, — CNBC's Michael Bloom Organizations: Devon Energy, Chevron, Wall Street, CNBC, Blackstone, Capri Holdings Locations: capex, Guyana, Delaware, Devon, Israel
CNBC Pro looked for stocks that are within 5% of a 52-week high and are up more than 1% so far this month. That is, the consensus price target on these stocks call for a gain of at least 5%. Shares are currently 3.3% off from the 52-week high. Wall Street sees further gains for the name, as analysts' consensus price target suggests upside of 8% from here. Other names on the verge of a breakout include drug wholesale company Cencora , Vertex Pharmaceuticals and natural gas company Targa Resources .
Persons: FANG, Scott Gruber, — CNBC's Michael Bloom Organizations: Google, Microsoft, Amazon, Intel, CNBC, Big Tech, Investors, Diamondback Energy, Analysts, Citi, Diamondback, Citi Research, Vertex Pharmaceuticals, Targa Resources
At last, bitcoin has broken out of a tight trading range, potentially heralding greater highs from here. Investors should expect higher lows and higher highs in the bitcoin price over the next few months, chart analysts say. Wald said he's eyeing the 200-day moving average of $28,000 as a potential new support level while bitcoin runs into key retracement levels of its 2021-22 decline. Many chart analysts considered the previous support level to be about $25,000. For Julius de Kempenaer, senior technical analyst at StockCharts.com, bitcoin's former resistance level of roughly $31,000 could now become support, with the next resistance level ranging as high as $47,000 to $48,000.
Persons: bitcoin, Bitcoin, Ari Wald, Oppenheimer, it's, " Wald, he's, Jonathan Krinsky, Julius de Kempenaer, de Kempenaer, Michael Bloom Organizations: CNBC
Utilities, beloved for their dividend payments, are under pressure in today's high rate environment, but a few gems stand out in the tarnished sector, according to Bank of America. The sector has suffered through 2023, shedding 16%, as the Federal Reserve continues to roll out its policy-tightening campaign. But there are a few opportunities in the sector, even as Bank of America says utilities aren't particularly compelling now. Both are also deemed top buys by Bank of America. PG & E has a California rate case development coming on Nov. 2, when the California Public Utilities Commission will be meeting.
Persons: Julien Dumoulin, Smith, ConEd, Michael Bloom Organizations: Bank of America, Federal Reserve, Consolidated Edison, E Corporation, PPL Corporation, California Public Utilities Commission, Kentucky Public Service Commission, PPL Locations: California, Kentucky
One place in the world stands as a beacon for investors in bank stocks: Japan. Japanese banks have outperformed in a year when U.S. banks have come under pressure both from rapidly rising interest rates and the regional banking crisis last spring. "We've been bullish on Japanese banks for a long time," said Chen Zhao, chief global strategist at Alpine Macro. Part of what's driving the bull case for Japanese banks is the country's yield curve. While the U.S. and other developed economies contend with an inverted yield curve that's weighing on financial profit margins, Japan continues to have a positive yield curve.
Persons: We've, Chen Zhao, Zhao, JPMorgan's Marko Kolanovic, Japan's, Kolanovic, — CNBC's Michael Bloom Organizations: JPMorgan, Regional Banking, Treasury, Japan Post Bank, Chiba Bank, JPMorgan BetaBuilders Japan, Resona Holdings Locations: Japan, U.S, EWJ
Rocket Pharmaceuticals shares are poised to nearly quadruple as it rolls out its lineup of late-stage targeted gene therapies, according to Cantor Fitzgerald. RCKT YTD mountain RCKT YTD chart Analyst Josh Schimmer called the stock one of his "top picks" as its products address unmet medical needs. It also benefits from a "thoughtful management team with a knack for identifying compelling gene therapy programs," he said. Schimmer is extremely bullish on Rocket's portfolio of advanced gene therapy products. "RCKT should be stacking larger and larger gene therapy programs," the analyst wrote.
Persons: Cantor Fitzgerald, Josh Schimmer, Schimmer, — CNBC's Michael Bloom Organizations: Rocket Pharmaceuticals
The use of Eli Lilly 's Mounjaro for weight loss can pull shoppers away from the snack aisle — though the transition will likely be gradual, according to Morgan Stanley. Kaufman noted a six-week study presented at ObesityWeek that showed users of Mounjaro cut calories and weight at a faster clip. The study also produced evidence that medication takers had a "significant reduction in food consumption," as well as fewer cravings for sweets and fast food fats. And while taking Mounjaro reduced food cravings overall, it had a particular impact on sweets, the study found. All four of the snack makers Kaufman said to watch have lost share value in 2023.
Persons: Eli Lilly, Morgan Stanley, Mounjaro, Pamela Kaufman, Kaufman, Hershey, Campbell, — CNBC's Michael Bloom Organizations: Drug Administration, Hershey, Brand Locations: Mondelez
A panic spike could send stocks higher heading into November, according to Bank of America. Notably, the S & P 500 closed below its 200-day moving average, suggesting a break in the uptrend, and drew near a key psychological support level at 4,200. Bank of America's Stephen Suttmeier said the CBOE 3-Month Volatility Index (VIX3M) and the CBOE Volatility Index (VIX) could flash an oversold reading below 1.0 as the S & P 500 nears its support levels, a possible capitulation signal indicating it's time for investors to buy. Regardless, Bank of America broadly anticipates the S & P 500 will close the year out at 4,600, according to the CNBC Market Strategist Survey . "In our view, this tactical panic likely coincides with a break below the 200-day MA at 4233 (SPX closed below it on 10/20) and the "FOMO rally / soft-landing" breakout point near 4200 on the SPX," Suttmeier added.
Persons: Stocks, of America's Stephen Suttmeier, Suttmeier, — CNBC's Michael Bloom Organizations: Bank of America, of America's, U.S ., Treasury, CNBC Market, Survey
Investors should focus on stocks with strong balance sheets as these companies tend to be more resilient against high interest rates, according to Goldman Sachs. Bond yields have been surging lately as the Federal Reserve signaled higher rates for longer in its inflation fight. Higher rates make it more expensive to borrow, and they effectively lower the present value of any future earnings. Stocks with strong balance sheets have outperformed those with weak ones by 4 percentage points since the start of September, Goldman said. Meanwhile, investors are rotating away from stocks perceived to be vulnerable to the higher rate backdrop, including those with levered balance sheets, Goldman said.
Persons: Goldman Sachs, David Kostin, Goldman, Kostin, CNBC's Michael Bloom Organizations: Federal Reserve, Companies, Big Tech, Netflix, Nvidia, Colgate, Palmolive, Costco, American Airlines, Caesars Entertainment, Delta Air Lines
Investors should scoop up shares of medical device provider AtriCure , according to JMP Securities, which expects the company to be a winner in one burgeoning medical device market. AtriCure develops, manufactures and sells devices that are used for the treatment of atrial fibrillation, or Afib; left atrial appendage management, or LAAM; and post-operative pain. The company's stock price has declined just about 19% so far this year, with almost all of that occurring this quarter. ATRC YTD mountain AtriCure stock. AtriCure's pain management division "adds an attractive layer of growth that should outpace ATRC's legacy product portfolios," Stauder said.
Persons: Daniel Stauder, Stauder, bode, AtriCure, — CNBC's Michael Bloom Organizations: JMP Securities
Tuesday General Motors is set to report earnings before the bell, followed by a call at 8:30 a.m. Coca-Cola is set to report earnings in the premarket, with a call slated for 8:30 .am. Wednesday Boeing is set to report earnings in the premarket, with leadership scheduled to hold a call at 10:30 a.m. Ford Motor is set to report earnings after the bell, followed by a conference call at 5 p.m. This quarter: The e-commerce giant is expected to report earnings per share growth of more than 100%, according to LSEG.
Persons: Michael Wayland, they'll, Andrea Teixeira, MSFT, Jordan Novet, GOOGL, Justin Post, MRK, Goldman Sachs, Chris Shibutani, Keytruda, Ford, AMZN, Doug Anmuth, — CNBC's Michael Bloom Organizations: Big Tech, Microsoft, Meta, Wall, CNBC, GM, LSEG, United Auto Workers, Investment Group, Coca, U.S, Activision, Wednesday Boeing, Boeing, Management, Bank of America, IBM, Merck, Ford, UAW, Detroit, JPMorgan Locations: Missouri, EVs, China, Apptio
Multiple Wall Street analysts are sticking by their bullish calls on Blackstone despite a disappointing third quarter, telling investors that now is the time to buy the stock. Shares of Blackstone fell nearly 8% on Thursday after earnings and revenue came in short of estimates, according to FactSet's StreetAccount. BX 3M mountain Blackstone's stock has fallen sharply over the past month. But Oppenheimer analyst Chris Kotowski said in a note to clients Friday that the move in the alternative asset manager's stock is an overreaction and that investors should buy the dip. "Blackstone (BX) has been exhibiting relative strength – including with its strong investment performance (especially in private credit and infrastructure).
Persons: Blackstone, FactSet's, Oppenheimer, Chris Kotowski, Kotowski, Craig Siegenthaler, Siegenthaler, Jon Gray, Gray, — CNBC's Michael Bloom Organizations: Blackstone, Bank of America, The Bank of America
Mattel has a bright future ahead as it rides the residuals of the Barbie movie's success, according to Citi. The stock climbed nearly 22% from the end of June into July, aided by hype around the Barbie movie released in July. MAT YTD mountain Mattel YTD chart Despite this rally, analyst James Hardiman thinks there are more gains ahead stemming from Mattel's balance sheet deleveraging. "The company's focus on increasing profitability has resulted in over $1.25B in cost savings since 2018 with an additional ~$50M expected in 2H23. Of course, this increasing profitability has directly resulted from Mattel's strong industry-leading position – and the unprecedented success of the Barbie movie.
Persons: Barbie, James Hardiman, , Michael Bloom Organizations: Mattel, Citi, MAT Locations: 2H23
Softening demand means that investors should consider pivoting away from solar stocks, according to Deutsche Bank. The firm downgraded three solar names to hold from buy: SolarEdge , Sunrun and Sunnova . Deutsche lowered the price target for SolarEdge to $150 — implying a 32% potential upside from the stock's closing price Thursday — from $300. Those comments, along with SolarEdge cutting its third-quarter revenue guidance, put pressure on the broader solar sector. Earnings season for the solar industry kicks off with Sunnova reporting results on Oct. 25.
Persons: Deutsche, Sunnova, SolarEdge, Sunrun, Corinne Blanchard, whittle, Blanchard, there's, — CNBC's Michael Bloom Organizations: Deutsche Bank, NOVA, Bloomberg Locations: U.S, Northeastern U.S, Southern, China
A major chipmaker is getting a lot of love on Wall Street — and no, it's not Nvidia . Taiwan Semiconductor Manufacturing Company posted third-quarter results Thursday that topped analysts' expectations. While the company reported its largest profit decline since 2019, it signaled a looming end to a difficult inventory correction. The Taiwan-based semiconductor company plays an integral role in the attention-grabbing artificial intelligence chipmaking industry, supplying products to Apple , Nvidia and Advanced Micro Devices . However, now may mark an opportune time for long-term investors to get into a company poised to experience mid- to high-teens growth in 2024.
Persons: Goldman Sachs, Bruce Lu, Lu, Brad Lin, Gokul Hariharan, Hariharan, — CNBC's Michael Bloom Organizations: Nvidia, Taiwan Semiconductor Manufacturing Company, Taiwan Semiconductor, Apple, Bank of America, JPMorgan Locations: 2024E, Taiwan, China, U.S
A stock with a 14-day RSI greater than 70 is considered to be overbought and at risk of a pullback. Here are some of the most overbought names: Sports apparel retailer Nike has a 14-day RSI of 81.89, and just under half of analysts covering the stock rate it a buy. Lockheed Martin is another one of the most overbought companies in the S & P 500. The U.S. defense contractor scored a 14-day RSI of 77.69, with a consensus price target implying 6.8% upside. Also on the oversold list is pharmaceutical company Moderna , which has a 14-day RSI reading of 15.5.
Persons: Piper Sandler, Lockheed Martin, Invesco, Jason Haas, Haas, — CNBC's Michael Bloom Organizations: Nike, Dow Jones, CNBC Pro, Insurance, Cardinal Health, Allstate, Humana, Investment, Hasbro, Wall, Bank of America, Monopoly, Moderna, Pfizer, FedEx Locations: U.S, Lowe's
Solaredge 's warning on Thursday of weakening European demand was another red flag following what has already been a tumultuous year for the solar industry. Several Wall Street investment banks downgraded SolarEdge and slashed their price targets in reaction to the preannouncement. Deutsche Bank downgraded SolarEdge , along with peer solar stocks Sunrun and Sunnova , to a hold rating from buy. Analyst Corinne Blanchard halved SolarEdge's price target to $150 from $300, although this still implies 32% potential upside from the stock's Thursday close. Besides waning European demand, Blanchard highlighted that U.S. demand has also declined and may not bottom until early 2024.
Persons: Solaredge, Zvi Lando, Enphase, SunPower, Sunrun, bode, Gordon Haskett, Don Bilson, Corinne Blanchard, Blanchard, Goldman Sachs, SolarEdge, Goldman, Brian Lee, Oppenheimer, Roth, Philip Shen, Julien Dumoulin, Smith, Michael Bloom Organizations: Deutsche Bank, Bank of America Locations: California, SolarEdge, U.S
Investors may not be fully pricing in Merck 's strong treatment pipeline, according to UBS. Analyst Trung Huynh expects that "underappreciated pipeline readouts" will be the primary contributor to multiple expansion for the company. Huynh also noted that investors continue to underestimate the value of two key Merck treatments: Keytruda — used in cancer immunotherapy — and Gardasil, a vaccine targeting HPV. The analyst added that these two treatments and other underappreciated catalysts have all contributed to Merck's above-peer growth profile. The upgrade comes after the Food and Drug Administration approved the use of Keytruda for treatment with "platinum-containing chemotherapy as neoadjuvant treatment " on Monday.
Persons: Trung Huynh, Huynh, , Michael Bloom Organizations: Merck, UBS, Food and Drug Administration Locations: China
Total: 25